BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1845155)

  • 1. High-dose pooled immunoglobulin in the therapy of systemic vasculitis.
    Jayne DR; Lockwood CM
    Trans Assoc Am Physicians; 1991; 104():304-12. PubMed ID: 1845155
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of autoimmune diseases and systemic vasculitis with pooled human intravenous immune globulin.
    Jordan SC; Toyoda M
    Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):31-8. PubMed ID: 8033432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pooled intravenous immunoglobulin in the management of systemic vasculitis.
    Jayne DR; Lockwood CM
    Adv Exp Med Biol; 1993; 336():469-72. PubMed ID: 8296659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ANCA anti-idiotype antibodies and the treatment of systemic vasculitis with intravenous immunoglobulin.
    Jayne DR; Esnault VL; Lockwood CM
    J Autoimmun; 1993 Apr; 6(2):207-19. PubMed ID: 8499059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Preliminary results of intravenous immunoglobulins in treating patients with vasculitis].
    Antonelli A; Agostini G; Agostini S
    Clin Ter; 1992 Sep; 141(9 Pt 2):33-6. PubMed ID: 1468195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary systemic vasculitis.
    Day C; Savage C
    Minerva Med; 2001 Oct; 92(5):349-63. PubMed ID: 11675579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Animal models of systemic vasculitis.
    Mathieson PW; Qasim FJ; Esnault VL; Oliveira DB
    J Autoimmun; 1993 Apr; 6(2):251-64. PubMed ID: 8388693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous immunoglobulin as sole therapy for systemic vasculitis.
    Jayne DR; Lockwood CM
    Br J Rheumatol; 1996 Nov; 35(11):1150-3. PubMed ID: 8948304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic vasculitis treatment and monitoring update, 2008.
    Yazici Y
    Bull NYU Hosp Jt Dis; 2008; 66(3):228-30. PubMed ID: 18937637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antineutrophil cytoplasmic antibody associated vasculitis and renal failure in Behçet's disease.
    Khan IH; Catto GR; MacLeod AM
    Nephrol Dial Transplant; 1994; 9(3):332. PubMed ID: 8052448
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical and anatomopathological study of 5 patients with vasculitis and anti-neutrophil cytoplasmic antibodies with cytoplasmatic pattern].
    Fierro JA; Cuchacovic R; Rodríguez MS; Parra MA; Soto MC
    Rev Med Chil; 1995 Jul; 123(7):841-8. PubMed ID: 8560115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of systemic vasculitis with pooled intravenous immunoglobulin.
    Jayne DR; Davies MJ; Fox CJ; Black CM; Lockwood CM
    Lancet; 1991 May; 337(8750):1137-9. PubMed ID: 1674023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous immunoglobulin (IVIg) therapy in MPO-ANCA related polyangiitis with rapidly progressive glomerulonephritis in Japan.
    Muso E; Ito-Ihara T; Ono T; Imai E; Yamagata K; Akamatsu A; Suzuki K
    Jpn J Infect Dis; 2004 Oct; 57(5):S17-8. PubMed ID: 15507757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antineutrophil cytoplasmic antibodies in systemic vasculitis].
    Radu AS; Bueno C; Bonfá ES; Cossermelli W
    Rev Hosp Clin Fac Med Sao Paulo; 1993; 48(6):264-71. PubMed ID: 8029598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of refractory and/or severe ANCA-associated systemic necrotizing vasculitides.
    Guillevin L; Pagnoux C
    Isr Med Assoc J; 2008 Jan; 10(1):89-91. PubMed ID: 18300585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Part 3: Newer therapies for ANCA-associated vasculitis.
    Jayne D
    Clin Exp Rheumatol; 2007; 25(1 Suppl 44):S77-9. PubMed ID: 17428377
    [No Abstract]   [Full Text] [Related]  

  • 17. New aspects in the management of ANCA-positive vasculitis.
    Levy J
    Nephrol Dial Transplant; 2001 Jul; 16(7):1314-7. PubMed ID: 11427616
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical and pathological characteristics and outcomes of Chinese patients with primary anti-neutrophil cytoplasmic antibodies-associated systemic vasculitis with immune complex deposition in kidney.
    Yu F; Chen M; Wang SX; Zou WZ; Zhao MH; Wang HY
    Nephrology (Carlton); 2007 Feb; 12(1):74-80. PubMed ID: 17295665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antineutrophil cytoplasmic autoantibody-associated small-vessel vasculitis.
    Kallenberg CG
    Curr Opin Rheumatol; 2007 Jan; 19(1):17-24. PubMed ID: 17143091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating levels of soluble adhesion molecules in patients with ANCA-associated vasculitis.
    Di Lorenzo G; Pacor ML; Mansueto P; Lo Bianco C; Di Natale E; Rapisarda F; Pellitteri ME; Ditta V; Gioè A; Giammarresi G; Rini GB; Li Vecchi M
    J Nephrol; 2004; 17(6):800-7. PubMed ID: 15593054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.